150 related articles for article (PubMed ID: 14505115)
1. Proteases in brain tumour progression.
Levicar N; Nuttall RK; Lah TT
Acta Neurochir (Wien); 2003 Sep; 145(9):825-38. PubMed ID: 14505115
[TBL] [Abstract][Full Text] [Related]
2. Proteases and their inhibitors in human brain tumours: a review.
Rooprai HK; McCormick D
Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
[TBL] [Abstract][Full Text] [Related]
3. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of glioma invasiveness: the role of proteases.
Rao JS
Nat Rev Cancer; 2003 Jul; 3(7):489-501. PubMed ID: 12835669
[TBL] [Abstract][Full Text] [Related]
5. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
7. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
8. Pericellular proteases in angiogenesis and vasculogenesis.
van Hinsbergh VW; Engelse MA; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
10. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
11. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
12. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
Zhang D; Samani AA; Brodt P
Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
[TBL] [Abstract][Full Text] [Related]
13. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
Poincloux R; Lizárraga F; Chavrier P
J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
[TBL] [Abstract][Full Text] [Related]
14. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of proteases as anticancer drugs.
Jedinak A; Maliar T
Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
17. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
18. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ
Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779
[TBL] [Abstract][Full Text] [Related]
19. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
Bellail AC; Hunter SB; Brat DJ; Tan C; Van Meir EG
Int J Biochem Cell Biol; 2004 Jun; 36(6):1046-69. PubMed ID: 15094120
[TBL] [Abstract][Full Text] [Related]
20. Effect of compressive force on the expression of MMPs, PAs, and their inhibitors in osteoblastic Saos-2 cells.
Mitsui N; Suzuki N; Koyama Y; Yanagisawa M; Otsuka K; Shimizu N; Maeno M
Life Sci; 2006 Jul; 79(6):575-83. PubMed ID: 16516240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]